Rubicon Organics Inc
XTSX:ROMJ
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.33
0.68
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CA |
|
Rubicon Organics Inc
XTSX:ROMJ
|
32.9m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
524.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
275.8B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.2B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
276.4B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
219.6B CHF |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
147.2B USD |
Loading...
|
Market Distribution
| Min | -4 710 029.9% |
| 30th Percentile | -65.8% |
| Median | -2.4% |
| 70th Percentile | 11% |
| Max | 71 100% |
Other Profitability Ratios
Rubicon Organics Inc
Glance View
Rubicon Organics, Inc. engages in the building of super-premium organic cannabis brands. The company is headquartered in Vancouver, British Columbia and currently employs 141 full-time employees. The company went IPO on 2018-10-10. The Company, through its subsidiary, Rubicon Holdings Corp, is engaged in cultivating, processing and selling organic certified cannabis products, which it sells under its owned and licensed brands. The firm's brands include Simply Bare Organic, Lab Theory, 1964 Supply Co., and Wildflower. The company has invested in round organic growing conditions, which includes two different spectrums of supplemental light, advanced climate and humidity controls, cold cure processing rooms and processing facilities for dried flower and solvent-less extraction. The firm is licensed to cultivate, process and sell cannabis products from both its 125,000 square feet greenhouse located in Delta, British Columbia, Canada and 11-acre outdoor grow site for recreational and medical-use markets in Canada.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Rubicon Organics Inc is 31.5%, which is above its 3-year median of 27.9%.
Over the last 3 years, Rubicon Organics Inc’s Operating Margin has increased from 26.1% to 31.5%. During this period, it reached a low of 22.8% on Jun 30, 2024 and a high of 35.6% on Mar 31, 2023.